OMCLOMNICELL, INC.

Nasdaq omnicell.com


$ 27.86 $ 0.58 (2.13 %)    

Friday, 19-Apr-2024 15:59:55 EDT
QQQ $ 414.59 $ -8.76 (-2.07 %)
DIA $ 379.83 $ 1.96 (0.52 %)
SPY $ 494.96 $ -4.36 (-0.87 %)
TLT $ 89.15 $ 0.32 (0.36 %)
GLD $ 221.02 $ 0.69 (0.31 %)
$ 27.83
$ 27.52
$ 27.82 x 100
$ 27.87 x 200
$ 27.45 - $ 27.97
$ 25.69 - $ 77.14
331,950
na
1.26B
$ 1.01
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 02-28-2024 12-31-2023 10-K
2 11-03-2023 09-30-2023 10-Q
3 08-04-2023 06-30-2023 10-Q
4 05-05-2023 03-31-2023 10-Q
5 03-01-2023 12-31-2022 10-K
6 11-04-2022 09-30-2022 10-Q
7 08-08-2022 06-30-2022 10-Q
8 05-09-2022 03-31-2022 10-Q
9 02-25-2022 12-31-2021 10-K
10 11-05-2021 09-30-2021 10-Q
11 08-06-2021 06-30-2021 10-Q
12 05-04-2021 03-31-2021 10-Q
13 02-24-2021 12-31-2020 10-K
14 10-30-2020 09-30-2020 10-Q
15 07-31-2020 06-30-2020 10-Q
16 05-08-2020 03-31-2020 10-Q
17 02-26-2020 12-31-2019 10-K
18 11-01-2019 09-30-2019 10-Q
19 08-02-2019 06-30-2019 10-Q
20 05-03-2019 03-31-2019 10-Q
21 02-27-2019 12-31-2018 10-K
22 11-02-2018 09-30-2018 10-Q
23 08-03-2018 06-30-2018 10-Q
24 05-04-2018 03-31-2018 10-Q
25 02-27-2018 12-31-2017 10-K
26 11-03-2017 09-30-2017 10-Q
27 08-04-2017 06-30-2017 10-Q
28 05-05-2017 03-31-2017 10-Q
29 02-28-2017 12-31-2016 10-K
30 11-07-2016 09-30-2016 10-Q
31 08-05-2016 06-30-2016 10-Q
32 05-06-2016 03-31-2016 10-Q
33 02-26-2016 12-31-2015 10-K
34 11-06-2015 09-30-2015 10-Q
35 08-07-2015 06-30-2015 10-Q
36 05-08-2015 03-31-2015 10-Q
37 03-30-2015 12-31-2014 10-K
38 11-10-2014 09-30-2014 10-Q
39 08-07-2014 06-30-2014 10-Q
40 05-12-2014 03-31-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 omnicell-announces-xt-amplify-a-multi-year-innovation-program-that-is-intended-to-maximize-value-for-hospitals-health-systems-and-post-acute-care-facilities-that-have-invested-in-omnicells-xt-automated-dispensing-system

Multi-year Innovation Program Designed to Maximize Value and Outcomes for XT Automated Dispensing SystemOmnicell, Inc. (NASDAQ:...

 benchmark-maintains-buy-on-omnicell-lowers-price-target-to-38

Benchmark analyst Bill Sutherland maintains Omnicell (NASDAQ:OMCL) with a Buy and lowers the price target from $42 to $38.

 wells-fargo-maintains-equal-weight-on-omnicell-lowers-price-target-to-26

Wells Fargo analyst Stan Berenshteyn maintains Omnicell (NASDAQ:OMCL) with a Equal-Weight and lowers the price target from $...

 omnicell-expects-q1-revenue-of-232m-242m-vs-26237m-est-adj-eps-of-010-000-vs-031-est-fy24-revenue-of-1045b-1120b-vs-108b-est-adj-eps-of-090-140-vs-166-est

The table below summarizes Omnicell's 2024 guidance outlined above.   Q1 2024   ...

 omnicell-q4-adj-eps-033-beats-015-estimate-sales-25885m-beat-25556m-estimate

Omnicell (NASDAQ:OMCL) reported quarterly earnings of $0.33 per share which beat the analyst consensus estimate of $0.15 by 120...

 earnings-scheduled-for-february-8-2024

Companies Reporting Before The Bell • Ares Management (NYSE:ARES) is expected to report quarterly earnings at $1.09 per share ...

 wells-fargo-upgrades-omnicell-to-equal-weight-lowers-price-target-to-28

Wells Fargo analyst Stan Berenshteyn upgrades Omnicell (NASDAQ:OMCL) from Underweight to Equal-Weight and lowers the price t...

 btig-downgrades-omnicell-to-neutral

BTIG analyst David Larsen downgrades Omnicell (NASDAQ:OMCL) from Buy to Neutral.

 piper-sandler-upgrades-omnicell-to-overweight-lowers-price-target-to-39

Piper Sandler analyst Sean Wieland upgrades Omnicell (NASDAQ:OMCL) from Neutral to Overweight and lowers the price target fr...

 why-staar-surgical-shares-are-trading-lower-by-around-16-here-are-other-stocks-moving-in-thursdays-mid-day-session

Gainers OmniLit Acquisition Corp. (NASDAQ: OLIT) jumped 53.2% to $15.53. OmniLit announced that its merger with Syntec was a...

 omnicell-announces-headcount-reduction-expects-12m-18m-in-non-recurring-costs

RestructuringOmnicell plans to take action as it relates to cost containment across the business, including a headcount reducti...

 omnicell-sees-q4-2023-revenue-247m-267m-vs-29967m-est

For the fourth quarter of 2023, the Company expects total revenues to be between $247 million and $267 million. The Company exp...

 earnings-scheduled-for-november-2-2023

Companies Reporting Before The Bell • AudioCodes (NASDAQ:AUDC) is estimated to report quarterly earnings at $0.18 per share on...

 keybanc-downgrades-omnicell-to-sector-weight

Keybanc analyst Scott Schoenhaus downgrades Omnicell (NASDAQ:OMCL) from Overweight to Sector Weight.

 stocks-that-hit-52-week-lows-on-wednesday

  On Wednesday, 311 stocks hit new 52-week lows.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION